Previous Article | Next Article 
Infection and Immunity, April 2001, p. 2723-2727, Vol. 69, No. 4
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.4.2723-2727.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Intracellular Crystal Formation as a Mechanism of
Cytotoxicity in Murine Pulmonary Cryptococcus
neoformans Infection
Marta
Feldmesser,1,*
Yvonne
Kress,2 and
Arturo
Casadevall1,3
Division of Infectious Diseases, Department
of Medicine,1 Department of
Pathology,2 and Department of
Microbiology and Immunology,3 Albert
Einstein College of Medicine, Bronx, New York
Received 17 November 2000/Returned for modification 27 December
2000/Accepted 13 January 2001
 |
ABSTRACT |
Rod-like crystalline structures formed during eosinophilic
Cryptococcus neoformans pneumonia in C57BL/6 mice.
Crystals were found associated with yeast cells and free in host cell
cytoplasm. The crystals apparently formed because of the interaction of
a host protein with the cryptococcal polysaccharide. Crystal formation likely contributes to pathogenesis by causing cellular damage.
 |
TEXT |
Cryptococcus neoformans
causes life-threatening disease in 5 to 10% of patients with AIDS in
the United States (32) and 30% of those in Africa
(8). C. neoformans is unique among the pathogenic fungi in that it is encapsulated, yet it can be a
facultative intracellular pathogen (9, 15). The
cryptococcal polysaccharide capsule is required for virulence
(17, 26) and interferes with multiple aspects of host
immune responses (3). Polysaccharide accumulation is also
associated with host cell destruction (15, 28).
Crystal formation during the inflammatory response to microbial agents
is a relatively rare phenomenon. Crystalline inflammation has been
associated with eosinophils, and pulmonary cryptococcal infection in
some strains produces eosinophilic pneumonia (23, 24). In
C57BL/6 mice, eosinophilic pneumonia is common 14 days after primary
pulmonary infection (13). Crystalline pneumonia has been
recently described for murine cryptococcal infection, with the crystals
being assessed to be Charcot-Leyden crystals (22). During
studies of pulmonary C. neoformans infection in C57BL/6
mice, we noted rod-like crystalline structures in close apposition to
yeast cells. Crystal structures with similar appearance in macrophages
of numerous species have been described (7, 25, 27, 29, 34,
35). In the murine lung, their presence has been termed
acidophilic macrophage pneumonia, and this phenomenon occurs with
varying frequency in healthy mice and in mice with various disease
states (20, 36, 37). C57BL/6 mice are particularly prone to crystal formation (31). Recently, crystals with
similar appearance have been shown to consist of Ym1
(T-lymphocyte-derived eosinophil chemotactic factor) (19).
Ultrastructure of crystals in murine infection.
Cultures of
C. neoformans ATCC 24067, obtained from the American
Type Culture Collection (Manassas, Va.) (16), were
maintained, grown, and prepared as previously described
(15). For animal studies, the guidelines for animal
experimentation of the Albert Einstein College of Medicine were
followed. Six- to 10-week-old C57BL/6 mice from the National Cancer
Institute (Bethesda, Md.) and from Jackson Laboratories (Bar Harbor,
Maine) were used in most experiments. Additional experiments were done
with 129/SvJ (Jackson Laboratories), 129/SvEv (Taconic Farms,
Germantown, N.Y.), and A/JCr (National Cancer Institute) mice.
These strains were selected because we have used them for other studies
of pulmonary cryptococcosis (12, 15). Mice were infected
by intratracheal inoculation of 104 organisms of
C. neoformans, as described previously (12).
Mice were killed by cervical dislocation, their lungs were removed, and
one lobe was fixed in 10% buffered formalin for light microscopy. The
remainder of the lung was processed for electron microscopy, as
described previously (13). C57BL/6 mice were studied 14 days after infection (three experiments) and 28 days after infection (two experiments). 129/SvEv, 129/SvJ, and A/JCr mice were each studied
14 and 28 days after infection in one experiment. Two mice were studied
in each experimental group.
Crystalline structures were seen in the lungs of all C57BL/6 mice
infected with C. neoformans in five of five independent experiments but were rarely seen in A/JCr, 129/SvEv, or
129/SvJ mice. In C57BL/6 mice, crystals were commonly seen 14 days after infection by transmission electron microscopy (Fig.
1). They were rarely
present in lung tissue studied at earlier times after infection (data
not shown). Deposits with the structural appearance of membranes were
seen on the outer surfaces of the crystals and at times appeared to
form a surrounding membrane (data not shown). The crystals were present
in increased numbers 28 days after infection, at which time they often
formed parallel stacks. The thickness of the crystalline structures
appeared to be a multiple of the initial crystal thickness, suggesting
side-to-side stacking. An internal structure was visible in some, with
ultradense bands oriented along either the long or the short axis of
the crystal. The distance between ultradense bands was determined by
measuring the number of bands in 5 to 10 mm inside 10 crystals
magnified 150,000 times. The mean distance between ultradense bands in
either orientation was 0.42 nm (standard deviation, ±0.04 nm). An
electron-dense ring frequently formed around the outer aspect of the
cryptococcal polysaccharide capsule, with electron density and
thickness similar to those of the crystals. The crystals were most
often located in large multinucleated cells of macrophage origin based
upon staining with Griffonia simplicifolia agglutinin B4
isolectin (14) but were occasionally inside eosinophils.
Crystals were seen in cells containing C. neoformans
and were absent from uninfected areas. Cells containing large numbers
of crystals appeared to be dying, as they had rounded nuclei,
clumped chromatin, and cytoplasmic disruption. Crystals protruded
through the membrane of some cells, suggesting that crystal formation
can lead to membrane disruption. By 28 days after infection, crystals
were found extracellularly and in association with bronchial
epithelial disruption.

View larger version (154K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Eosinophils recruited to the site of infection
discharge electron-dense granular contents at the surface of an
extracellular Cryptococcus, organism, allowing contact
of cryptococcal polysaccharide with granule proteins (day 14;
magnification, ×3,000). (B) The location of the yeast cell and
crystals within a large multinucleated cell at a magnification lower
than that for panel A. An electron-dense rim forms around the yeast
cell, and crystals subsequently polymerize in contact with yeast and in
the cytoplasm (day 14; magnification, ×2,000). (C) Budding
intracellular C. neoformans in murine lung tissue 14 days after infection with electron-dense rim surrounding the
polysaccharide capsule. Crystals formed in association with the yeast
cell (magnification, ×4,000). (D) On day 28 after infection, large
numbers of crystals were seen inside multinucleated cells, some of
which were dying (magnification, ×2,000). (E) Crystals disrupted host
cell membranes and became extracellular (day 28 after infection;
magnification, ×3,000). (F) Higher magnification of the area enclosed
in the boxed area in panel E demonstrates membrane disruption
(magnification, ×20,000). (G and H) On day 28 after infection,
crystals disrupted the bronchial epithelium, with loss of cilia.
Epithelial cell debris and larger extracellular crystals were seen
inside bronchi (magnification, ×1,000).
|
|
Immunoelectron microscopy.
Because the appearance of the
crystals was similar to that of eosinophil-specific granule cores (data
not shown) (31), we initially hypothesized that they were
composed of eosinophilic major basic protein (MBP). Staining of the
crystals with eosin demonstrated their acidophilic nature
(Fig. 2). Polyclonal rabbit antiserum to murine MBP was generously donated by James J. Lee and Nancy A. Lee (Mayo Clinic, Scottsdale, Ariz.). Unicryl-embedded (BB
International, Cardiff, England), ultrathin lung tissue sections were blocked and then incubated in rabbit antiserum to murine MBP
diluted 1:100 or in prebled rabbit serum for 1 h at room
temperature. Grids were then incubated in goat anti-rabbit
immunoglobulin G (IgG) conjugated to 10-nm-diameter gold
particles (Goldmark Biologicals, Phillipsburg, N.J.) diluted
1:30 for 2 h at room temperature and fixed in 2% glutaraldehyde.
Immunoelectron microscopy showed binding of immune antiserum to murine
MBP to the eosinophil-specific granule core and matrix but not to the
crystals. No labeling of eosinophils was seen with normal rabbit serum.
The electron density of the crystals was similar to that of the
cryptococcal cell wall, which contains polymerized melanin in vivo. To
investigate whether the crystals were melanin, we performed
immunoelectron microscopy with two melanin-binding monoclonal
antibodies (MAbs), 11B1 or 6D2 (both IgM), or murine IgM
(Southern Biotechnology Associates, Birmingham, Ala.) as a control, as
described previously (33). The crystals remained
unlabeled, although gold particles were observed in the cryptococcal
cell wall, which is consistent with cell wall melanization
(33). Next, we evaluated whether the crystals were
composed of polysaccharide, which is abundant in infected tissue
(18). In 1-µm-thick deplasticized sections, the
crystals did not stain with periodic acid Schiff's reagents, which
stain polysaccharide. Localization of C. neoformans capsular polysaccharide (CNPS) by immunoelectron microscopy was done on ultrathin sections of Epon-embedded tissue by using MAb 2H1, an IgG1
that binds to glucuronoxylomannan, the major component of capsular
polysaccharide, as described previously (4, 5). Murine IgG
(Sigma) was used as a control. CNPS was identified in vacuoles
containing the crystals and surrounding the outer membranes of the
crystals, but the crystals were not labeled (Fig. 3). On the basis of these results, we
concluded that the crystals were not composed of MBP, melanin, or
polysaccharide.

View larger version (60K):
[in this window]
[in a new window]
|
FIG. 2.
Light microscopic staining of intracellular crystals
(arrows). (A) Crystals from a 1-µm-thick section of mouse lung 14 days after infection stained with eosin. (B) Staining of a 5-µm-thick
section of mouse lung 28 days after infection with hematoxylin and
eosin showing a macrophage containing a large number of intracellular
crystals. Magnification, ×1,000 (panels A and B).
|
|

View larger version (140K):
[in this window]
[in a new window]
|
FIG. 3.
Immunoelctron microscopy shows the presence of gold
label for cryptococcal polysaccharide surrounding the outer membrane of
the crystals but not over the crystals. The asterisk is located on a
cryptococcal capsule. The arrow points to artifactual contraction of
the capsule from the edge of a phagosome. magnification, ×15,000).
|
|
In vitro crystal formation.
Peritoneal inflammatory cells from
male Sprague Dawley rats from the National Cancer Institute and Charles
River Laboratories (Raleigh, N.C.) were obtained as described
previously (13). Rats were used for this experiment
because they are a plentiful source of peritoneal inflammatory cells
that contain a high percentage of eosinophils. Nonadherent cells were
plated in 24-well plates at a final concentration of 1.5 × 106 cells in 1 ml of RPMI containing 10%
heat-inactivated fetal calf serum with 1% penicillin or streptomycin
(incubation medium). C. neoformans strains ATCC 24067, 3501, or Cap 67 (an acapsular strain isogenic with strain 3501) were added at
a final concentration of 1.5 × 105 yeast
cells/ml. To induce phagocytosis of C. neoformans and
eosinophil degranulation, 200 µg of MAb 2H1/ml was added, and the
plates were incubated at 37°C with 8% CO2.
Every 24 h, the medium was aspirated and replaced with 1 ml of
medium with 200 µg of MAb 2H1/ml. At various times after
infection, the contents of the wells were aspirated, centrifuged at
330 × g for 5 min, and resuspended in Trump's
fixative. Cell blocks were embedded in araldite-Epon and processed for
electron microscopy as described above. For each specimen, all areas of
five noncontiguous grids were examined. In a preliminary experiment,
crystal formation was maximal after incubation for 3 days and was less
evident at 24 h. After incubation for 5 days, wells were
overwhelmed with C. neoformans and most cells had
degenerated. As a result, incubation for 3 days was used for subsequent
experiments. Crystals formed in large numbers when either of two
encapsulated strains of C. neoformans and MAb to the
polysaccharide capsule were added to rat peritoneal inflammatory cells
(Fig. 4). In contrast, crystals rarely
formed when an acapsular strain was used.

View larger version (122K):
[in this window]
[in a new window]
|
FIG. 4.
Crystals formed after incubation of C.
neoformans strain 24067 with rat peritoneal inflammatory
cells in vitro for 3 days. Bar, 1 µm.
|
|
CNPS from ATCC 3501 was isolated as described previously
(
6). Rat peritoneal inflammatory cells were prepared as
described
above, and 1.5 × 10
6 cells in
incubation medium were incubated with 1, 10, or 100
µg of CNPS/ml and
200 µg of MAb 2H1/ml for 3 days at 37°C. The
incubation medium was
changed daily. For the sample containing
1 µg of CNPS/ml, additional
CNPS was added on days 1 and 2. For
the 10-µg/ml sample, additional
CNPS was added on day 2. In all
wells containing CNPS, MAb 2H1 was
added to the replacement medium
on days 1 and 2 at a final
concentration of 200 µg/ml. To demonstrate
a requirement for capsular
polysaccharide for crystal formation,
1.5 × 10
6 sheep
erythrocytes (RBCs) conjugated to MAb 2H1 were incubated
with
eosinophils under the same conditions. Sheep RBCs were conjugated
to
MAb 2H1 by incubation of a 5% cell suspension in 0.25% glutaraldehyde
for 1 h at room temperature with continuous stirring
(
2,
30).
Attachment of MAb 2H1 to the RBC surface was
assessed by demonstration
of agglutination following the addition of
CNPS. Crystals formed
in assays containing 1 or 10 µg of
CNPS/ml and MAb 2H1. When 100
µg of CNPS/ml was used, inflammatory
cells degenerated. The addition
of complexes of CNPS and MAb induced
frequent crystal formation,
whereas very rare crystals formed when
antigen-antibody complexes
consisting of sheep RBCs conjugated to
anticapsular MAb were added
to inflammatory cells, despite
internalization of these complexes.
These results demonstrate that
capsular polysaccharide contributes
to crystal formation. Although we
cannot definitively state that
these crystals are the same as those
observed in murine pulmonary
infection because homology of murine Ym1
with a rat eosinophil
chemotactic factor is unknown, similar crystals
in rats have been
described previously (
34).
Crystals with an appearance similar to those in the present study have
been associated with eosinophilic infiltrates (
1,
11,
21,
31,
37). Consequently, many investigators have
hypothesized that
they represent a crystallized eosinophil protein,
such as
lysophospholipase (Charcot-Leyden crystals) (
22,
37).
However, Charcot-Leyden crystals from nonprimate species have
never
been definitively described (
10,
11). Rather, the recent
report identifying very similar crystals as composed of an eosinophil
chemotactic factor, Ym1, provides the likely explanation for the
coincidence of crystals and eosinophil infiltrates, as eosinophils
are
recruited in response to this protein (
19). That Ym1 has
chitinase activity and is present in large amounts in association
with
C. neoformans, which, like other fungi, contains cell wall
chitin, supports the view of Guo et al. (19) that Ym1 may be part
of
the host response to microorganisms that contain chitin. Further,
these
investigators suggest that Ym1 may be involved in binding
to
extracellular polysaccharide. Here, we found that crystals
formed at
the edge of the polysaccharide capsule and were closely
associated with
cytoplasmic CNPS deposits. CNPS is a polysaccharide
with a high
molecular weight, which may promote protein polymerization
through
excluded volume effects in the
phagosome.
Crystal formation appears to be a cytotoxic phenomenon. The formation
of larger collections of these structures was associated
with
disruption and death of macrophages and bronchial epithelial
cell
destruction. Since macrophages are the principal effector
cells against
C. neoformans, crystal formation may interfere with
host
defense mechanisms and promote persistence of infection.
Furthermore,
polymerization of a host cell protein by exposure
to CNPS during
cryptococcal infection may eliminate a potentially
microbicidal protein
from solution. The reason for the strikingly
frequent appearance of
these polymers in murine cryptococcal pneumonia
may be related to two
unusual qualities of this fungal infection:
chronicity and abundant
polysaccharide production in tissue. The
conversion of a host cell
protein from an effector molecule into
a polymer that damages host
cells may represent a novel mechanism
of virulence for CNPS and may
contribute to the chronicity and
persistence associated with
cryptococcal infection. While the
overall impact of crystal formation
in cryptococcal infection
is unknown, the association of crystals with
disrupted cells suggests
that the net effect of crystal formation is
harmful to the
host.
 |
ACKNOWLEDGMENTS |
This work was supported by NIH grant AI01341 (M.F.), by NIH grants
AI33774, AI33142, and HL59842 (A.C.), and by a Burroughs Wellcome
Developmental Therapeutics Award (A.C.). This support is gratefully acknowledged.
We thank James J. Lee and Nancy A. Lee for generously providing
antiserum to murine MBP, Gerald Gleich, Liise-Anne Pirofski, and
Matthew Scharff for critical reading of the manuscript, Ann Dvorak for
helpful discussion, Jorge Bermudez for processing of tissue for light
microscopy, and Clemen Cayetano and Valentin Storovoytov for technical
assistance with electron microscopy.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Marta
Feldmesser, Albert Einstein College of Medicine, Golding Building, Room
701, 1300 Morris Park Ave., Bronx, NY 10461. Phone: (718) 430-3730. Fax: (718) 430-8701. E-mail: feldmess{at}aecom.yu.edu.
Editor:
T. R. Kozel
 |
REFERENCES |
| 1.
|
Ali, B. A.,
J. R. Shortland, and G. Hudson.
1981.
Origin of crystalloid inclusions in macrophages. II. Evidence for derivation from eosinophil granulocyte breakdown.
Br. J. Exp. Pathol.
62:662-668[Medline].
|
| 2.
|
Avrameas, S.
1969.
Coupling of enzymes to proteins with glutaraldehyde. Use of the conjugates for the detection of antigens and antibodies.
Immunochemistry
6:43-52[CrossRef][Medline].
|
| 3.
|
Buchanan, K. L., and J. W. Murphy.
1998.
What makes Cryptococcus neoformans a pathogen?
Emerg. Infect. Dis.
4:71-83[Medline].
|
| 4.
|
Casadevall, A.,
W. Cleare,
M. Feldmesser,
A. Glatman-Freedman,
D. L. Goldman,
T. R. Kozel,
N. Lendvai,
J. Mukherjee,
L.-A. Pirofski,
J. Rivera,
A. L. Rosas,
M. D. Scharff,
P. Valadon,
K. Westin, and Z. Zhong.
1998.
Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.
Antimicrob. Agents Chemother.
42:1437-1446[Abstract/Free Full Text].
|
| 5.
|
Casadevall, A.,
J. Mukherjee,
S. J. N. Devi,
R. Schneerson,
J. B. Robbins, and M. D. Scharff.
1992.
Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection.
J. Infect. Dis.
165:1086-1093[Medline].
|
| 6.
|
Cherniak, R.,
E. Reiss, and S. H. Turner.
1982.
A galactoxylomannan antigen of Cryptococcus neoformans serotype A.
Carbohydr. Res.
103:239-250[CrossRef].
|
| 7.
|
Collet, A. J.
1970.
Fine structure of the alveolar macrophage of the cat and modifications of its cytoplasmic components during phagocytosis.
Anat. Rec.
167:277-290[CrossRef][Medline].
|
| 8.
|
Desmet, P.,
K. D. Kayembe, and C. De Vroey.
1989.
The value of cryptococcal serum antigen screening among HIV-positive/AIDS patients in Kinshasa, Zaire.
AIDS
3:77-78[Medline].
|
| 9.
|
Diamond, R. D., and J. E. Bennett.
1973.
Growth of Cryptococcus neoformans within human macrophages in vitro.
Infect. Immun.
7:231-236[Abstract/Free Full Text].
|
| 10.
|
Dvorak, A. M.,
P. F. Weller,
R. A. Monahan-Earley,
L. Letourneau, and S. J. Ackerman.
1990.
Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) and peroxidase in macrophages, eosinophils, and extracellular matrix of the skin in the hypereosinophilic syndrome.
Lab. Investig.
62:590-607[Medline].
|
| 11.
|
El-Hashimi, W.
1971.
Charcot-Leyden crystals.
Am. J. Pathol.
65:311-324[Medline].
|
| 12.
|
Feldmesser, M., and A. Casadevall.
1997.
Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection.
J. Immunol.
158:790-799[Abstract].
|
| 13.
|
Feldmesser, M.,
A. Casadevall,
Y. Kress,
G. Spira, and A. Orlofsky.
1997.
Eosinophil-Cryptococcus neoformans interactions in vivo and in vitro.
Infect. Immun.
65:1899-1907[Abstract].
|
| 14.
|
Feldmesser, M.,
Y. Kress, and A. Casadevall.
1998.
Effect of antibody to capsular polysaccharide on eosinophilic pneumonia in murine infection with Cryptococcus neoformans.
J. Infect. Dis.
177:1639-1646[Medline].
|
| 15.
|
Feldmesser, M.,
Y. Kress,
P. Novikoff, and A. Casadevall.
2000.
Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection.
Infect. Immun.
68:4225-4237[Abstract/Free Full Text].
|
| 16.
|
Franzot, S. P.,
J. Mukherjee,
R. Cherniak,
L.-C. Chen,
J. S. Hamdan, and A. Casadevall.
1998.
Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes.
Infect. Immun.
66:89-97[Abstract/Free Full Text].
|
| 17.
|
Fromtling, R. A.,
H. J. Shadomy, and E. S. Jacobson.
1982.
Decreased virulence in stable, acapsular mutants of Cryptococcus neoformans.
Mycopathologia
79:23-29[CrossRef][Medline].
|
| 18.
|
Goldman, D. L.,
S. C. Lee, and A. Casadevall.
1995.
Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody.
Infect. Immun.
63:3448-3453[Abstract].
|
| 19.
|
Guo, L.,
R. S. Johnson, and J. C. Schuh.
2000.
Biochemical characterization of endogenously formed eosinophilic crystals in the lungs of mice.
J. Biol. Chem.
275:8032-8037[Abstract/Free Full Text].
|
| 20.
|
Horn, H. A.,
C. C. Congdon,
A. B. Eschenbrenner,
H. B. Andervont, and H. L. Stewart.
1952.
Pulmonary adenomatosis in mice.
J. Natl. Cancer Inst.
12:1297-1315.
|
| 21.
|
Hudson, G.
1968.
Crystalloid material in macrophages of mouse bone marrow.
Acta Anat.
71:100-107[Medline].
|
| 22.
|
Huffnagle, G. B.,
M. B. Boyd,
N. E. Street, and M. F. Lipscomb.
1998.
IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6).
J. Immunol.
160:2393-2400[Abstract/Free Full Text].
|
| 23.
|
Huffnagle, G. B.,
G.-H. Chen,
J. L. Curtis,
R. A. McDonald,
R. M. Strieter, and G. B. Toews.
1995.
Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans.
J. Immunol.
155:3507-3516[Abstract].
|
| 24.
|
Huffnagle, G. B.,
M. F. Lipscomb,
J. A. Lovchik,
K. A. Hoag, and N. E. Street.
1994.
The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection.
J. Leukoc. Biol.
55:35-42[Abstract].
|
| 25.
|
Komiyama, A., and S. S. Spicer.
1975.
Microendocytosis in eosinophilic leukocytes.
J. Cell Biol.
64:622-635[Abstract/Free Full Text].
|
| 26.
|
Kozel, T. R., and J. Cazin, Jr.
1971.
Nonencapsulated variant of Cryptococcus neoformans. I. Virulence studies and characterization of soluble polysaccharide.
Infect. Immun.
3:287-294[Abstract/Free Full Text].
|
| 27.
|
Leake, E. S., and M. J. Wright.
1976.
The fine structure of lung macrophages from rhesus and squirrel monkeys, with special reference to the large numbers of mitochondria.
Am. Rev. Respir. Dis.
114:581-592[Medline].
|
| 28.
|
Lee, S. C.,
Y. Kress,
M.-L. Zhao,
D. W. Dickson, and A. Casadevall.
1995.
Cryptococcus neoformans survive and replicate in human microglia.
Lab. Investig.
73:871-879[Medline].
|
| 29.
|
Marshall, G. E.,
J. R. Shortland, and G. Hudson.
1988.
Crystalloid material in cells of the murine mononuclear phagocyte system.
J. Anat.
157:217-228[Medline].
|
| 30.
|
Mota, G.,
C. Galatiue,
J. Sjoquist, and V. Ghetie.
1983.
A non-dissociable IgG-protein A complex.
Ann. Immunol.
134C:331-340.
|
| 31.
|
Murray, A. B., and A. Luz.
1990.
Acidophilic macrophage pneumonia in laboratory mice.
Vet. Pathol.
27:274-281[Abstract].
|
| 32.
|
Powderly, W. G.
1993.
Cryptococcal meningitis and AIDS.
Clin. Infect. Dis.
17:837-842[Medline].
|
| 33.
|
Rosas, A. L.,
J. D. Nosanchuk,
M. Feldmesser,
G. M. Cox,
H. C. McDade, and A. Casadevall.
2000.
Synthesis of polymerized melanin by Cryptococcus neoformans in infected rodents.
Infect. Immun.
68:2845-2853[Abstract/Free Full Text].
|
| 34.
|
Simon, Gerard T.
1980.
Splenic macrophages, p. 469-497.
In
I. Carr, and W. T. Daems (ed.), The reticuloendothelial system: a comprehensive treatise. I. Morphology. Plenum Press, London, United Kingdom.
|
| 35.
|
Simon, G. T., and J. S. Burke.
1970.
Electron microscopy of the spleen.
Am. J. Pathol.
58:451-469[Medline].
|
| 36.
|
Ward, J. M.
1978.
Pulmonary pathology of the motheaten mouse.
Vet. Pathol.
15:170-178[Abstract].
|
| 37.
|
Zyngier, F. R., and A. Brockbank.
1974.
Electron microscopy of the lung in experimental Toxocara canis infection.
Ann. Trop. Med. Parasitol.
68:229-233[Medline].
|
Infection and Immunity, April 2001, p. 2723-2727, Vol. 69, No. 4
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.4.2723-2727.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Osterholzer, J. J., Surana, R., Milam, J. E., Montano, G. T., Chen, G.-H., Sonstein, J., Curtis, J. L., Huffnagle, G. B., Toews, G. B., Olszewski, M. A.
(2009). Cryptococcal Urease Promotes the Accumulation of Immature Dendritic Cells and a Non-Protective T2 Immune Response within the Lung. Am. J. Pathol.
174: 932-943
[Abstract]
[Full Text]
-
Milam, J. E., Herring-Palmer, A. C., Pandrangi, R., McDonald, R. A., Huffnagle, G. B., Toews, G. B.
(2007). Modulation of the Pulmonary Type 2 T-Cell Response to Cryptococcus neoformans by Intratracheal Delivery of a Tumor Necrosis Factor Alpha-Expressing Adenoviral Vector. Infect. Immun.
75: 4951-4958
[Abstract]
[Full Text]
-
Hoenerhoff, M. J., Starost, M. F., Ward, J. M.
(2006). Eosinophilic Crystalline Pneumonia as a Major Cause of Death in 129S4/SvJae Mice.. Vet Pathol
43: 682-688
[Abstract]
[Full Text]
-
Arora, S., Hernandez, Y., Erb-Downward, J. R., McDonald, R. A., Toews, G. B., Huffnagle, G. B.
(2005). Role of IFN-{gamma} in Regulating T2 Immunity and the Development of Alternatively Activated Macrophages during Allergic Bronchopulmonary Mycosis. J. Immunol.
174: 6346-6356
[Abstract]
[Full Text]
-
Hernandez, Y., Arora, S., Erb-Downward, J. R., McDonald, R. A., Toews, G. B., Huffnagle, G. B.
(2005). Distinct Roles for IL-4 and IL-10 in Regulating T2 Immunity during Allergic Bronchopulmonary Mycosis. J. Immunol.
174: 1027-1036
[Abstract]
[Full Text]
-
Falcone, F. H., Loke, P'n., Zang, X., MacDonald, A. S., Maizels, R. M., Allen, J. E.
(2001). A Brugia malayi Homolog of Macrophage Migration Inhibitory Factor Reveals an Important Link Between Macrophages and Eosinophil Recruitment During Nematode Infection. J. Immunol.
167: 5348-5354
[Abstract]
[Full Text]